KTTA
Price
$0.55
Change
+$0.01 (+1.85%)
Updated
Jun 23, 04:10 PM (EDT)
Capitalization
17.94M
71 days until earnings call
Intraday BUY SELL Signals
VRCA
Price
$5.78
Change
+$0.14 (+2.48%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
96.89M
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KTTA vs VRCA

KTTA vs VRCA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KTTA vs. VRCA commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KTTA is a Hold and VRCA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (KTTA: $0.54 vs. VRCA: $5.64)
Brand notoriety: KTTA and VRCA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KTTA: 125% vs. VRCA: 156%
Market capitalization -- KTTA: $17.94M vs. VRCA: $96.89M
KTTA [@Biotechnology] is valued at $17.94M. VRCA’s [@Biotechnology] market capitalization is $96.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KTTA’s FA Score shows that 1 FA rating(s) are green whileVRCA’s FA Score has 0 green FA rating(s).

  • KTTA’s FA Score: 1 green, 4 red.
  • VRCA’s FA Score: 0 green, 5 red.
According to our system of comparison, VRCA is a better buy in the long-term than KTTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KTTA’s TA Score shows that 4 TA indicator(s) are bullish while VRCA’s TA Score has 2 bullish TA indicator(s).

  • KTTA’s TA Score: 4 bullish, 5 bearish.
  • VRCA’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, KTTA is a better buy in the short-term than VRCA.

Price Growth

KTTA (@Biotechnology) experienced а -4.12% price change this week, while VRCA (@Biotechnology) price change was -2.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

KTTA is expected to report earnings on Sep 02, 2026.

VRCA is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRCA($96.9M) has a higher market cap than KTTA($17.9M). VRCA YTD gains are higher at: -32.130 vs. KTTA (-58.376). VRCA has higher annual earnings (EBITDA): -11.36M vs. KTTA (-21.4M). KTTA has more cash in the bank: 50.4M vs. VRCA (20.6M). KTTA has less debt than VRCA: KTTA (0) vs VRCA (1.44M). VRCA has higher revenues than KTTA: VRCA (37.2M) vs KTTA (0).
KTTAVRCAKTTA / VRCA
Capitalization17.9M96.9M18%
EBITDA-21.4M-11.36M188%
Gain YTD-58.376-32.130182%
P/E RatioN/AN/A-
Revenue037.2M-
Total Cash50.4M20.6M245%
Total Debt01.44M-
FUNDAMENTALS RATINGS
VRCA: Fundamental Ratings
VRCA
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
19

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KTTAVRCA
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
74%
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KTTA
Daily Signal:
Gain/Loss:
VRCA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVS12.570.66
+5.54%
Corvus Pharmaceuticals
OPBK14.430.07
+0.45%
OP Bancorp
GBTG9.390.03
+0.32%
Global Business Travel Group
AEON0.66-0.01
-1.32%
AEON Biopharma
TEL212.69-4.95
-2.27%
TE CONNECTIVITY Ltd

KTTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KTTA has been loosely correlated with VRCA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if KTTA jumps, then VRCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
+7.39%
VRCA - KTTA
34%
Loosely correlated
+0.18%
FATE - KTTA
32%
Poorly correlated
+2.39%
AGIO - KTTA
29%
Poorly correlated
+2.72%
DMRA - KTTA
29%
Poorly correlated
+12.29%
BCYC - KTTA
28%
Poorly correlated
-0.63%
More